For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251219:nRSS2052Ma&default-theme=true
RNS Number : 2052M EMV Capital PLC 18 December 2025
EMV Capital plc
(EMVC, Group or the Company)
Director/PDMR Dealing
EMV Capital Plc (AIM: EMVC), the deep tech and life sciences VC investment
group, announces that on 18 December 2025 the Company was notified that
Jonathan Robinson, Senior Independent Director, has transferred 34,484
ordinary shares of 5 pence each in the Company ("Ordinary Shares") from his
personal brokerage account to his Self-Invested Personal Pension for portfolio
consolidation purposes at a price of £0.5807 pence per Ordinary Share. This
transfer was effected by way of a sale and repurchase of the Ordinary Shares.
Following the above transactions and as set out in the table below, the number
and beneficial ownership of Ordinary Shares held by Jonathan Robinson is
unchanged.
Director/ PDMR Position Existing interest in Ordinary Shares Ordinary Shares purchased Ordinary Shares sold Total number of Ordinary Shares in which interested Total interest in Company's issued share capital
Dr Jonathan Robinson Senior Independent Director 233,737 34,484 34,484 233,737 0.84%
The information below, set out in accordance with the requirements of the UK
Market Abuse Regulation, provides further detail on the issue of the
Subscription Shares and the Director Dealings.
The person responsible for arranging the release of this announcement on
behalf of the Company is Ed Hooper, Executive Director and General Counsel of
the Company.
-ends-
For more information, please contact:
EMV Capital plc via Rosewood
Ilian Iliev, CEO
Panmure Liberum Limited (NOMAD and Broker) +44 (0)20 7886 2500
Emma Earl / Will Goode / Freddy Crossley / Mark Rogers (Corporate Finance)
Rupert Dearden (Corporate Broking)
Rosewood (Financial PR) +44 (0)20 7653 8702
John West / Llewellyn Angus / Lily Pearce
About EMV Capital plc (EMVC)
EMV Capital plc is a deep tech and life sciences venture capital investment
group with an international portfolio of high-growth companies.
With a strategic focus on generating superior returns for investors from the
fast-growing sectors and technologies that will define our future; EMV Capital
invests in, manages and strengthens early-stage IP-rich companies.
EMV Capital holds both direct equity stakes and carried interest in its
portfolio companies, creating an evergreen structure that supports extensive
growth and value creation. EMV Capital's investment thesis is realised through
these capital sources:
· capital-efficient investments through the Group balance sheet;
· fund management of the Evergreen EIS and Martlet Capital Funds; and
· syndicated investments leveraging its network of third-party
investors.
EMV Capital's approach is characterised by its proactive management style,
aiming to advance portfolio companies to critical value inflection points by
actively engaging with them. Companies are supported through Board
representation and the use of its Value Creation Services practice.
Headquartered in London, with a Cambridge presence and strong international
links, EMV Capital is quoted on the AIM market of the London Stock Exchange.
www.emvcapital.com (http://www.emvcapital.com/)
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Dr Jonathan Robinson
2 Reason for the notification
a) Position/status Director
b) Initial notification /Amendment Initial Notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name EMV Capital plc
b) LEI 213800N5WD46G1Y7I458
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument EMVC 5p Ordinary Shares
Identification code
GB00BN4R5Q82
b) Nature of the transaction Purchase of Ordinary Shares / Sale of Ordinary Shares
c) Price(s) and volume(s) Sale and repurchase
Price(s) Volume(s)
£0.5807 34,484 shares
d) Aggregated information N/a
- Aggregated volume
- Price
e) Date of the transaction 16 December 2025
f) Place of the transaction UK AIM
d)
Aggregated information
- Aggregated volume
- Price
N/a
e)
Date of the transaction
16 December 2025
f)
Place of the transaction
UK AIM
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHDBBDDCXBDGUI
Copyright 2019 Regulatory News Service, all rights reserved